David Gloss

10.5k total citations · 5 hit papers
57 papers, 6.5k citations indexed

About

David Gloss is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Gloss has authored 57 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 16 papers in Pediatrics, Perinatology and Child Health and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Gloss's work include Epilepsy research and treatment (24 papers), Neuroscience and Neuropharmacology Research (12 papers) and Pharmacological Effects and Toxicity Studies (12 papers). David Gloss is often cited by papers focused on Epilepsy research and treatment (24 papers), Neuroscience and Neuropharmacology Research (12 papers) and Pharmacological Effects and Toxicity Studies (12 papers). David Gloss collaborates with scholars based in United States, Canada and United Kingdom. David Gloss's co-authors include Gary Gronseth, Melissa J. Armstrong, Tamara Pringsheim, Alexander Rae‐Grant, Cynthia L. Harden, Ronald C. Petersen, Daniel Marson, Mary Ganguli, Oscar L. López and Gregory S. Day and has published in prestigious journals such as JAMA, Neurology and Cochrane Database of Systematic Reviews.

In The Last Decade

David Gloss

57 papers receiving 6.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practice guideline update summary: Mild cognitive impairment [RETIRED]

2017 1.4k citations Ronald C. Petersen, Oscar L. López et al. Neurology profile →
Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society

2016 764 citations David Gloss, Jacquelyn Bainbridge et al. Epiliepsy currents profile →
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]

2016 436 citations Gary Gronseth, Melissa J. Armstrong et al. Neurology profile →
Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors

2017 385 citations Cynthia L. Harden, David Gloss et al. Neurology profile →
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders [RETIRED]

2014 378 citations Gary Gronseth, David Gloss et al. Neurology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David Gloss	3.6k	1.6k	1.4k	1.4k	1.1k	57	6.5k
Gaetano Zaccara	2.8k 0.8×	2.2k 1.4×	1.1k 0.8×	957 0.7×	676 0.6×	165	5.2k
Francesco Monaco	2.8k 0.8×	929 0.6×	786 0.6×	734 0.5×	965 0.8×	170	6.4k
Manjari Tripathi	2.8k 0.8×	1.6k 1.0×	1.1k 0.8×	1000 0.7×	831 0.7×	385	6.6k
Tamara Pringsheim	5.7k 1.6×	1.9k 1.2×	1.4k 1.0×	2.0k 1.5×	2.0k 1.7×	205	12.3k
Kenneth I. Shulman	4.1k 1.1×	934 0.6×	1.8k 1.3×	1.0k 0.8×	2.7k 2.4×	189	10.2k
Stanley Berent	3.2k 0.9×	812 0.5×	1.4k 1.0×	1.9k 1.4×	1.2k 1.0×	114	7.8k
Cynthia L. Harden	4.2k 1.1×	2.9k 1.8×	1.5k 1.0×	984 0.7×	691 0.6×	161	6.3k
Vilho V. Myllylä	3.1k 0.9×	2.1k 1.3×	686 0.5×	1.1k 0.8×	1.8k 1.6×	149	7.9k
Michael Privitera	5.3k 1.5×	3.8k 2.3×	1.5k 1.1×	1.5k 1.1×	556 0.5×	168	7.7k
Ingmar Rosén	657 0.2×	1.0k 0.6×	1.0k 0.7×	1.4k 1.0×	1.0k 0.9×	122	5.9k

Countries citing papers authored by David Gloss

Since Specialization

Citations

This map shows the geographic impact of David Gloss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gloss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gloss more than expected).

Fields of papers citing papers by David Gloss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gloss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gloss. The network helps show where David Gloss may publish in the future.

Co-authorship network of co-authors of David Gloss

This figure shows the co-authorship network connecting the top 25 collaborators of David Gloss. A scholar is included among the top collaborators of David Gloss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gloss. David Gloss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ying, Tina Poklepović Peričić, Geertruida E Bekkering, et al.. (2023). How do network meta-analyses address intransitivity when assessing certainty of evidence: a systematic survey. BMJ Open. 13(11). e075212–e075212. 1 indexed citations

Sheidley, Beth Rosen, Jennifer Malinowski, Amanda L. Bergner, et al.. (2021). Genetic testing for the epilepsies: A systematic review. Epilepsia. 63(2). 375–387. 67 indexed citations

Tatum, William O., Jayanti Mani, Kazutaka Jin, et al.. (2021). Minimum standards for inpatient long-term video-EEG monitoring: A clinical practice guideline of the international league against epilepsy and international federation of clinical neurophysiology. Clinical Neurophysiology. 134. 111–128. 36 indexed citations

Vossler, David G., Jacquelyn Bainbridge, Jane Boggs, et al.. (2020). Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epiliepsy currents. 20(5). 245–264. 68 indexed citations

Oskoui, Maryam, Tamara Pringsheim, Yolanda Holler‐Managan, et al.. (2019). Practice guideline update summary: Acute treatment of migraine in children and adolescents. Neurology. 93(11). 487–499. 101 indexed citations

Tatum, William O., Guido Rubboli, Peter W. Kaplan, et al.. (2018). Clinical utility of EEG in diagnosing and monitoring epilepsy in adults. Clinical Neurophysiology. 129(5). 1056–1082. 190 indexed citations

Thompson, Stephanie, et al.. (2018). Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis. Epilepsy Research. 143. 1–6. 3 indexed citations

O’Connell, Brooke K., David Gloss, & Orrin Devinsky. (2017). Cannabinoids in treatment-resistant epilepsy: A review. Epilepsy & Behavior. 70(Pt B). 341–348. 158 indexed citations

Petersen, Ronald C., Oscar L. López, Melissa J. Armstrong, et al.. (2017). Practice guideline update summary: Mild cognitive impairment [RETIRED]. Neurology. 90(3). 126–135. 1431 indexed citations breakdown →

10.

Bilgili, Beliz, et al.. (2017). Utilizing Bi-Spectral Index (BIS) for the monitoring of sedated adult ICU patients: a systematic review. Minerva Anestesiologica. 83(3). 288 – 301. 13 indexed citations

11.

Gloss, David & Allan Krumholz. (2016). Managing an Unprovoked First Seizure in Adults. CNS Drugs. 30(3). 179–183. 3 indexed citations

12.

Winkelman, John W., Melissa J. Armstrong, Richard P. Allen, et al.. (2016). Practice guideline summary: Treatment of restless legs syndrome in adults [RETIRED]. Neurology. 87(24). 2585–2593. 152 indexed citations

13.

Gloss, David. (2015). An Overview of Products and Bias in Research. Neurotherapeutics. 12(4). 731–734. 41 indexed citations

14.

Gloss, David & Barbara G. Vickrey. (2014). Cannabinoids for epilepsy (Review). 1 indexed citations

15.

Wasterlain, Claude G., David Gloss, Jérôme Niquet, & Amy S. Wasterlain. (2013). Epileptogenesis in the developing brain. Handbook of clinical neurology. 111. 427–439. 12 indexed citations

16.

Morris, George L., David Gloss, Jeffrey Buchhalter, et al.. (2013). Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy. Neurology. 81(16). 1453–1459. 281 indexed citations

17.

Gloss, David & Barbara G. Vickrey. (2012). Cannabinoids for epilepsy. Cochrane Database of Systematic Reviews. CD009270–CD009270. 31 indexed citations

18.

Melgar, Miguel, Nitin R. Mariwalla, David Gloss, & John W. Walsh. (2006). Recurrent lymphocytic hypophysitis and bilateral intracavernous carotid artery occlusion. An observation and review of the literature. Neurological Research. 28(2). 177–183. 13 indexed citations

19.

Melgar, Miguel, José A. Rafols, David Gloss, & Fernando G. Díaz. (2005). Postischemic Reperfusion: Ultrastructural Blood-Brain Barrier and Hemodynamic Correlative Changes in an Awake Model of Transient Forebrain Ischemia. Neurosurgery. 56(3). 571–581. 29 indexed citations

20.

Gloss, David, et al.. (1981). Use of a Test of Psychomotor Ability in an Expanded Role. Perceptual and Motor Skills. 53(2). 659–662. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact